Added to YB: 2025-04-02
Pitch date: 2025-03-31
LOVE.V [neutral]
Cannara Biotech Inc.
+37.4%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada.
Market Cap
CAD 164.2M
Pitch Price
CAD 1.31
Price Target
N/A
Dividend
N/A
EV/EBITDA
6.75
P/E
12.36
EV/Sales
1.79
Sector
Personal Care Products
Category
growth
Show full summary:
Cannara Biotech: Making a Model
LOVE.V overview: Scaling to 24 grow zones in 3 years. $14M capex, $250M gross rev, 38.8% GM. Model shows 25.7% net income growth to $8.1M, but margin shrinks to 3.24%. Conservative est: $8.1M-$61.9M net income range. Minimal downside risk, upside potential from efficiencies, pricing, taxes.
Read full article (9 min)